c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis

Molecular and Cellular Biology

Volumn 20, Issue 4, 2000, Pages 1162-1169

  Stoneley, Mark ^a,c   Chappell, Stephen A ^b,c   Jopling, Catherine L ^c   Dickens, Martin ^c   MacFarlane, Marion ^c   Willis, Anne E ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INITIATION FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPORTER GENE; RIBOSOME; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSLATION INITIATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; GENES, MYC; HALF-LIFE; HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS C-MYC; RIBOSOMES; RNA, MESSENGER; STAUROSPORINE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EUKARYOTA;

EID: 0033956750     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.4.1162-1169.2000     Document Type: Article

References (64)

1. Amati, B., M. W. Brooks, N. Levy, T. D. Littlewood, G. I. Evan, and H. Land. 1993. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233-245.
2. Amati, B., T. D. Littlewood, G. I. Evan, and H. Land. 1993. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 12:5083-5087.
3. Ausubel, R. M., et al. 1987. Current protocols in molecular biology, p. 9.11-9.17. Wiley-Interscience, New York, N.Y.
4. Battey, J., C. Moulding, R. Taub, W. Murphy, T. Stewart, H. Potter, G. Lenoir, and P. Leder. 1983. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 34: 779-787.
5. Bentley, D. L., and M. Groudine. 1986, Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas. Mol. Cell. Biol. 6:3481-3489.
6. Bernstein, J., O. Sella, S. Le, and O. Elroy-Stein. 1997. PDGF/c-sis mRNA leader contains a differentiation-linked internal ribosomal entry site. J. Biol. Chem. 272:9356-9362.
7. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
8. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
9. Blackwood, E. M., B. Luscher, and R. N. Eisenman. 1992. Myc and Max associate in vivo. Genes Dev. 6:71-80.
10. Bronstein, I., J. Fortin, P. E. Stanley, G. S. Stewart, and L. J. Kricka. 1994. Chemiluminescent and bioluminescent reporter gene assays. Anal. Biochem. 219:169-181.
11. Butnick, N. Z., C. Miyamoto, R. Chizzonite, B. R. Cullen, G. Ju, and A. M. Skalka. 1985. Regulation of the human c-myc gene: 5′ noncoding sequences do not affect translation. Mol. Cell. Biol. 5:3009-3016.
12. Clemens, M. J., M. Bushell, and S. J. Morley. 1998. Degradation of eIF4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene 17:2921-2931.
13. Dang, C. V. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1-11.
14. De Benedetti, A., B. Joshi, J. R. Graff, and S. G. Zimmer. 1994. CHO cells are transformed by the translation initiation factor eIF-4E display increased levels of c-myc expression, but require concomitant overexpression of Max for tumorigenicity. Mol. Cell. Differ. 2:347-371.
15. De Benedetti, A., and R. E. Rhoads. 1990. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc. Natl. Acad. Sci. USA 87:8212-8216.
16. Devitt, A., O. C. Moffatt, C. Raykundalia, J. D. Capra, D. L. Simmons, and C. D. Gregory. 1998. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392:505-509.
17. Evan, G. I., and T. D. Littlewood. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3:44-49.
18. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
19. Fukunaga, F., and T. Hunter. 1997. MnK1, a new map kinase-activated protein kinase, isolated by novel expression screening method for identifying protein kinase substrates. EMBO J. 16:1921-1933.
20. Goodwin, R., and C. A. Smith. 1998. The TRAIL of death. Apoptosis 3:83-88.
21. Hann, S. R., and R. N. Eisenman. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486-2497.
22. Hueber, A. O., and G. I. Evan. 1998. Traps to catch unwary oncogenes. Trends Genet. 14:364-367.
23. Hueber, A. O., M. Zornig, D. Lyon, T. Suda, S. Nagata, and G. I. Evan. 1997. Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis. Science 278:1305-1309.
24. Jackson, R. J., S. L. Hunt, C. L. Gibbs, and A. Kaminski. 1994. Internal initiation of translation of picornavirus RNAs. Mol. Biol. Rep. 19:147-159.
25. Jackson, R. J., S. L. Hunt, J. E. Reynolds, and A. Kaminski. 1995. Capdependent and cap-independent translation: operational distinctions and mechanistic interpretations. Curr. Top. Microbiol. Immunol. 203:1-29.
26. Jackson, R. J., and A. Kaminski. 1995. Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA 1:985-1000.
27. Johannes, G., and P. Sarnow. 1998. Cap-independent polysomal association of natural mRNAs encoding c-myc. Bip, and eIF4F conferred by internal ribosome entry sites. RNA 4:1500-1513.
28. Juin, P., A. Hueber, T. Littlewood, and G. Evan. 1999 c-Myc-induced sensitization to apoptosis is mediated through cytochrome C release. Genes Dev. 13:1367-1381.
29. Juo, P., C. J. Kuo, S. E. Reynolds, R. F. Konz, J. Raingeaud, R. J. Davis, H.-P. Biemann, and J. Blenis. 1997. Fas activationb of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol. Cell. Biol. 17:24-35.
30. Kerkhoff, E., and E. B. Ziff. 1995. Deregulated messenger RNA expression during T cell apoptosis. Nucleic Acids Res. 23:4857-4863.
31. Kevil, C., P. Carter, B. Hu, and A. DeBenedetti. 1995. Translational enhancement of FGF-2 by eIF-4 factors and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 11:2339-2348.
32. Klefstrom, J., P. E. Kovanen, K. Somersalo, A.-O. Hueber, T. Littlewood, G. I. Evan, A. H. Greenberg, E. Saksela, T. Timonen, and K. Alitalo. 1999. c-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors. Oncogene 18:2181-2188.
33. Koromilas, A. E., A. Lazaris-Karatzas, and N. Sonenberg. 1991. mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF4E. EMBO J. 11:4153-4158.
34. Lamphear, B. J., R. Kirchweger, T. Skern, and R. E. Rhoads. 1995. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. J. Biol. Chem. 270:21975-21983.
35. Lee, C. H., P. Leeds, and R. J. Ross. 1998. Purification and characterization of a polysome-associated endoribonuclease that degrades c-myc mRNA in vitro. J. Biol. Chem. 273:25261-25271.
36. Lüscher, B., and R. N. Eisenman. 1988. c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol. Cell. Biol. 8:2504-2512.
37. MacFarlane, M., M. Ahmad, M. Srinivasula, T. Fernandes-Alnemri, G. M. Cohen, and E. S. Alnemri. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272:25417-25420.
38. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809-860.
39. Marissen, W., and R. E. Lloyd. 1998. Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol. Cell. Biol. 18:7565-7574.
40. Medema, J. P., C. Scaffidi, F. C. Kischkel, A. Shevchenko, M. Mann, P. H. Krammer, and M. E. Peter. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:2794-2804.
41. Miller, D., J. Dibbens, A. Damert, W. Risau, M. Vadas, and G. Goodall. 1998. The vascular endothelial growth factor mRNA contains an internal ribosome entry site. FEBS Lett. 434:417-420.
42. Morley, S. J., L. McKendrick, and M. Bushell. 1998. Cleavage of translation initiation factor 4G during anti-Fas 1gM-induced apoptosis does not require signalling through the p38 mitogen-activated protein kinase. FEBS Lett. 438:41-48.
43. Nanbru, C., I. Lafon, S. Audiger, G. Gensac, S. Vagner, G. Huez, and A.-C. Prats. 1997. Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J. Biol. Chem. 272:32061-32066.
44. Ohlmann, T., M. Rau, V. M. Pain, and S. J. Morley. 1996. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF-4E. EMBO J. 15:1371-1382.
45. Pain, V. M. 1996. Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem. 236:747-771.
46. Parkin, N., A. Darveau, R. Nicholson, and N. Sonenberg. 1988. cis-acting translational effects of the 5′ noncoding region of c-myc mRNA. Mol. Cell. Biol. 8:2875-2883.
47. Pestova, T., I. N. Shatsky, and C. U. T. Hellen. 1996. Functional dissection of eukaryotic initiation factor 4F: the 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes. Mol. Cell. Biol. 16:6870-6878.
48. Peter, M. E., and P. H. Krammer. 1998. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 10:545-551.
49. Proud, C. G., and R. M. Denton. 1997. Molecular mechanisms for the control of translation by insulin. Biochem. J. 328:329-341.
50. Raingeaud, J., A. J. Whilmarsh, B. Barrett, Y. Derijard, and R. J. Davis. 1996. MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247-1255.
51. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450.
52. Roulston, A., C. Reinhard, P. Amiri, and L. T. Williams. 1997 Early activation of c-jun N-terminal kinase and p38 kinase regulate cell survival response to tumour necrosis factor α. J. Biol. Chem. 273:10232-10239.
53. Saito, H., A. C. Hayday, K. Wiman, W. S. Hayward, and S. Tonegawa. 1983. Activation of the c-myc gene by translocation: a model for translational control. Proc. Natl. Acad. Sci. USA 80:7476-7460.
54. Savill, J., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14:131-136.
55. Schulze-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg, and M. E. Peter. 1998. Apoptosis signaling by death receptors. Eur. J. Biochem. 254:439-459.
56. Shindo, H., E. Tani, T. Matsumuto, T. Hashimoto, and J. Furuyama. 1993. Stabilization of c-myc protein in human glioma-cells. Acta Neuropathol. 86:345-352.
57. Spotts, G. D., and S. R. Hann. 1990. Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol. Cell. Biol. 10:3952-3964.
58. Stein, I., A. Itin, P. Einat, R. Skaliter, Z. Grossman, and E. Keshet. 1998. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell. Biol. 18:3112-3119.
59. Stoneley, M., F. E. M. Paulin, J. P. C. Le Quesne, S. A. Chappell, and A. E. Willis. 1998. C-Myc 5′ untranslated region contains an internal ribosome entry segment. Oncogene 16:423-428.
60. Vagner, S., M.-C. Gensac, A. Maret, F. Bayard, F. Amalric, H. Prats, and A.-C. Prats. 1995. Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol. Cell. Biol. 15:35-44.
61. Waskiewicz, A. J., A. Flynn, C. G. Proud, and J. A. Cooper. 1997. Mitogen-activated protein kinases activate the serine/threonine kinases MnK1 and MnK2. EMBO J. 16:1909-1920.
62. West, M. J., M. Stoneley, and A. E. Willis. 1998. Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway. Oncogene 17:769-780.
63. West, M. J., N. F. Sullivan, and A. E. Willis. 1995. Translational upregulation of the c-myc oncogene in Bloom's syndrome cell lines. Oncogene 13:2515-2524.
64. Yang, J.-Q., S. R. Bauer, J. F. Mushinski, and K. B. Marcu. 1985 Chromosome translocations clustered 5′ of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation. EMBO J. 4:1441-1447.